200 related articles for article (PubMed ID: 34290311)
1. CD276 is an important player in macrophage recruitment into the tumor and an upstream regulator for PAI-1.
Durlanik S; Fundel-Clemens K; Viollet C; Huber HJ; Lenter M; Kitt K; Pflanz S
Sci Rep; 2021 Jul; 11(1):14849. PubMed ID: 34290311
[TBL] [Abstract][Full Text] [Related]
2. Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature.
Seaman S; Zhu Z; Saha S; Zhang XM; Yang MY; Hilton MB; Morris K; Szot C; Morris H; Swing DA; Tessarollo L; Smith SW; Degrado S; Borkin D; Jain N; Scheiermann J; Feng Y; Wang Y; Li J; Welsch D; DeCrescenzo G; Chaudhary A; Zudaire E; Klarmann KD; Keller JR; Dimitrov DS; St Croix B
Cancer Cell; 2017 Apr; 31(4):501-515.e8. PubMed ID: 28399408
[TBL] [Abstract][Full Text] [Related]
3. A regulatory loop among CD276, miR-29c-3p, and Myc exists in cancer cells against natural killer cell cytotoxicity.
Lee CC; Ho KH; Huang TW; Shih CM; Hsu SY; Liu AJ; Chen KC
Life Sci; 2021 Jul; 277():119438. PubMed ID: 33798549
[TBL] [Abstract][Full Text] [Related]
4. Elevated Expression of the Immune Checkpoint Ligand CD276 (B7-H3) in Urothelial Carcinoma Cell Lines Correlates Negatively with the Cell Proliferation.
Harland N; Maurer FB; Abruzzese T; Bock C; Montes-Mojarro IA; Fend F; Aicher WK; Stenzl A; Amend B
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563359
[TBL] [Abstract][Full Text] [Related]
5. CD276 (B7-H3) Maintains Proliferation and Regulates Differentiation in Angiogenic Function in Late Endothelial Progenitor Cells.
Son Y; Kwon SM; Cho JY
Stem Cells; 2019 Mar; 37(3):382-394. PubMed ID: 30379377
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound molecular imaging in a human CD276 expression-modulated murine ovarian cancer model.
Lutz AM; Bachawal SV; Drescher CW; Pysz MA; Willmann JK; Gambhir SS
Clin Cancer Res; 2014 Mar; 20(5):1313-22. PubMed ID: 24389327
[TBL] [Abstract][Full Text] [Related]
7. Expression patterns of the immune checkpoint ligand CD276 in urothelial carcinoma.
Aicher WK; Korn M; Reitnauer L; Maurer FB; Hennenlotter J; Black PC; Todenhofer T; Bedke J; Stenzl A
BMC Urol; 2021 Apr; 21(1):60. PubMed ID: 33845814
[TBL] [Abstract][Full Text] [Related]
8. In Vitro Evaluation of CD276-CAR NK-92 Functionality, Migration and Invasion Potential in the Presence of Immune Inhibitory Factors of the Tumor Microenvironment.
Grote S; Ureña-Bailén G; Chan KC; Baden C; Mezger M; Handgretinger R; Schleicher S
Cells; 2021 Apr; 10(5):. PubMed ID: 33925968
[TBL] [Abstract][Full Text] [Related]
9. Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis.
Benzon B; Zhao SG; Haffner MC; Takhar M; Erho N; Yousefi K; Hurley P; Bishop JL; Tosoian J; Ghabili K; Alshalalfa M; Glavaris S; Simons BW; Tran P; Davicioni E; Karnes RJ; Boudadi K; Antonarakis ES; Schaeffer EM; Drake CG; Feng F; Ross AE
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):28-35. PubMed ID: 27801901
[TBL] [Abstract][Full Text] [Related]
10. Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy.
Picarda E; Ohaegbulam KC; Zang X
Clin Cancer Res; 2016 Jul; 22(14):3425-3431. PubMed ID: 27208063
[TBL] [Abstract][Full Text] [Related]
11. Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types.
Dai L; Guo X; Xing Z; Tao Y; Liang W; Shi Z; Hu W; Zhou S; Wang X
BMC Cancer; 2023 Jan; 23(1):102. PubMed ID: 36717836
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-187 inhibits tumor growth and invasion by directly targeting CD276 in colorectal cancer.
Wang ZS; Zhong M; Bian YH; Mu YF; Qin SL; Yu MH; Qin J
Oncotarget; 2016 Jul; 7(28):44266-44276. PubMed ID: 27329595
[TBL] [Abstract][Full Text] [Related]
13. B7-H3, a checkpoint molecule, as a target for cancer immunotherapy.
Yang S; Wei W; Zhao Q
Int J Biol Sci; 2020; 16(11):1767-1773. PubMed ID: 32398947
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis Reveals Distinct Immunological and Prognostic Characteristics of CD276/B7-H3 in Pan-Cancer.
Ding J; Sun Y; Sulaiman Z; Li C; Cheng Z; Liu S
Int J Gen Med; 2023; 16():367-391. PubMed ID: 36756390
[TBL] [Abstract][Full Text] [Related]
15. Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma.
Wang Z; Wang Z; Zhang C; Liu X; Li G; Liu S; Sun L; Liang J; Hu H; Liu Y; Zhang W; Jiang T
Cancer Sci; 2018 Sep; 109(9):2697-2705. PubMed ID: 30027617
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancer.
Mashiko S; Kitatani K; Toyoshima M; Ichimura A; Dan T; Usui T; Ishibashi M; Shigeta S; Nagase S; Miyata T; Yaegashi N
Cancer Biol Ther; 2015; 16(2):253-60. PubMed ID: 25587663
[TBL] [Abstract][Full Text] [Related]
17. New frontiers in immune checkpoint B7-H3 (CD276) research and drug development.
Getu AA; Tigabu A; Zhou M; Lu J; Fodstad Ø; Tan M
Mol Cancer; 2023 Mar; 22(1):43. PubMed ID: 36859240
[TBL] [Abstract][Full Text] [Related]
18. B7-H3 promotes multiple myeloma cell survival and proliferation by ROS-dependent activation of Src/STAT3 and c-Cbl-mediated degradation of SOCS3.
Lin L; Cao L; Liu Y; Wang K; Zhang X; Qin X; Zhao D; Hao J; Chang Y; Huang X; Liu B; Zhang J; Lu J; Ge Q
Leukemia; 2019 Jun; 33(6):1475-1486. PubMed ID: 30573782
[TBL] [Abstract][Full Text] [Related]
19. B7-H3/CD276: An Emerging Cancer Immunotherapy.
Zhou WT; Jin WL
Front Immunol; 2021; 12():701006. PubMed ID: 34349762
[TBL] [Abstract][Full Text] [Related]
20. Olive flounder CD276 (B7-H3) a coinhibitory molecule for T cells: Responses during viral hemorrhagic septicemia virus (VHSV) stimulation.
Hwang JY; Jeong JM; Kwon MG; Seo JS; Hwang SD; Son MH; Bae JS; Choi KM; Cho DH; Jeswin J; Park CI
Fish Shellfish Immunol; 2018 Feb; 73():228-233. PubMed ID: 29253650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
